ORIGINAL RESEARCH article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1549291

This article is part of the Research TopicEradicating Polio in Pakistan and Other Countries in the Eastern Mediterranean Region: Epidemiology, Surveillance, and ImmunizationView all 5 articles

Understanding barriers to stool adequacy: Results from a programmatic assessment of Pakistan's acute flaccid paralysis active surveillance system in 12 priority districts

Provisionally accepted
Keri  GeigerKeri Geiger1*Abul  AzizAbul Aziz2Chukwuma  MbaeyiChukwuma Mbaeyi1*Zainul  Abedin KhanZainul Abedin Khan2Mohammed  SoghaierMohammed Soghaier2Aimee  SummersAimee Summers2
  • 1Centers for Disease Control and Prevention (Georgia), Atlanta, Georgia
  • 2World Health Organization (Pakistan), Islamabad, Pakistan

The final, formatted version of the article will be published soon.

Pakistan’s acute flaccid paralysis (AFP) surveillance system is an essential part of efforts to eradicate poliomyelitis, as Pakistan and Afghanistan are the only countries where wild poliovirus remains endemic. The two primary performance indicators for AFP surveillance are the non-polio AFP rate for children aged <15 years and stool adequacy, defined as the percentage of AFP cases for which two timely stool samples arrive at the laboratory in good condition. Despite consistently meeting targets for both indicators at the national level, some districts in Pakistan failed to meet the stool adequacy target of >80% in 2023 or had declining stool adequacy. In March 2024, we assessed AFP surveillance in 12 districts in Pakistan with low stool adequacy to characterize barriers to meeting the target. The assessment included review of case investigation forms from AFP cases with patient paralysis onset during January 2023‒mid-March 2024 with inadequate stool samples, as well as visits to health facilities serving as active surveillance sites and interviews with surveillance and laboratory personnel. The most common barrier to stool adequacy was a delay between onset of paralysis and AFP case notification, which occurred in 111 of 158 (70%) inadequately sampled AFP cases reviewed. This delay was most frequently attributed to missed reporting by healthcare facilities, caretakers seeking healthcare many days after paralysis onset, or a combination of both. Additionally, only 63% of health facilities showed adequate active surveillance visit compliance. The assessment exposed gaps in AFP surveillance knowledge for some health facility staff, especially nurses and other paramedical or support professionals. Recommendations to improve the AFP surveillance system include monitoring and encouraging compliance with systematically scheduled health facility visits, increasing the frequency of AFP surveillance orientations, including paramedical professionals in AFP surveillance training, and developing a comprehensive messaging plan to increase knowledge about prompt reporting of AFP among healthcare providers and the public.

Keywords: Poliovirus, Polio eradication, vaccine preventable disease surveillance, active surveillance, Surveillance system

Received: 20 Dec 2024; Accepted: 14 Apr 2025.

Copyright: © 2025 Geiger, Aziz, Mbaeyi, Khan, Soghaier and Summers. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Keri Geiger, Centers for Disease Control and Prevention (Georgia), Atlanta, Georgia
Chukwuma Mbaeyi, Centers for Disease Control and Prevention (Georgia), Atlanta, Georgia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.